Why current SaaS models need to be disrupted to meet changing needs and realities

Commercial SaaS has become a fixed cost regardless of outcome

​

The previous evolution of rep-enablement software in healthcare was driven by new devices, integrated solutions, and the promise of cost savings through the software-as-a-service (SaaS) model that never materialized. Almost 10 years later, this approach to rep enablement has reached its limits in terms of utilization, effectiveness for modern rep roles, and driving further cost savings.

Recent advances in technology have the potential to reduce or eliminate device and integration barriers for most pharmaceutical sales and marketing teams, and new advances in pharma-specific rep enablement software have introduced efficiency through result-based SaaS pricing and tailored applications that maximize utilization that allows reps to activate their HCPs in new ways.

​

Download the free paper to analyze how you can fully maximize your field force’s impact through modern technologies